Original Research

Published on 18 Aug 2022

Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance

in Schizophrenia

Haishan Wu
Xijin Wang
Xuejun Liu
Hong Sang
Qijing Bo
Xiaodong Yang
Zhiyuan Xun
Keqing Li
Ruiling Zhang
Meijuan Sun

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.935769

2,222 views
2 citations

Editorial

Published on 18 Aug 2022

Editorial: Substance use and the psychosis spectrum

in Schizophrenia

Umut Kirli
Sinan Guloksuz
Hayriye Elbi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1004409

1,707 views
1 citation

Original Research

Published on 16 Aug 2022

The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia

in Schizophrenia

Hongna Li
Wenjin Chen
Mengzhuang Gou
Wei Li
Jinghui Tong
Yanfang Zhou
Ting Xie
Ting Yu
Wei Feng
Yanli Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.966657

2,574 views
6 citations

Original Research

Published on 12 Aug 2022

Peripheral inflammation levels associated with degree of advanced brain aging in schizophrenia

in Schizophrenia

Federica Klaus
Tanya T. Nguyen
Michael L. Thomas
Sharon C. Liou
Benchawanna Soontornniyomkij
Kyle Mitchell
Rebecca Daly
Ashley N. Sutherland
Dilip V. Jeste
Lisa T. Eyler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.966439

2,055 views
5 citations

Original Research

Published on 10 Aug 2022

Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia

in Schizophrenia

Daiki Sasabayashi
Yoichiro Takayanagi
Tsutomu Takahashi
Atsushi Furuichi
Haruko Kobayashi
Kyo Noguchi
Michio Suzuki

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.937605

1,832 views
2 citations

Original Research

Published on 09 Aug 2022

Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia

in Schizophrenia

Sumiao Zhou
Yuanyuan Huang
Qijie Kuang
Su Yan
Hehua Li
Kai Wu
Fengchun Wu
Xingbing Huang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.941479

1,945 views
4 citations

Original Research

Published on 04 Aug 2022

‘An experience of meaning’: A 20-year prospective analysis of delusional realities in schizophrenia and affective psychoses

in Schizophrenia

Cherise Rosen
Martin Harrow
Clara Humpston
Liping Tong
Thomas H. Jobe
Helen Harrow

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.940124

4,035 views
9 citations

Clinical Trial

Published on 04 Aug 2022

High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial

in Schizophrenia

Gry Bang-Kittilsen
John Abel Engh
René Holst
Tom Langerud Holmen
Therese Torgersen Bigseth
Eivind Andersen
Jon Mordal
Jens Egeland

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.921689

3,926 views
10 citations

Original Research

Published on 02 Aug 2022

Mindfulness, cognitive fusion, and self-compassion in patients with schizophrenia spectrum disorders—A cross-sectional study

in Schizophrenia

Kerem Böge
Franziska Pollex
Niklas Bergmann
Inge Hahne
Marco Matthäus Zierhut
Selin Mavituna
Neil Thomas
Eric Hahn

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.959467

3,795 views
12 citations

Original Research

Published on 28 Jul 2022

Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia

in Schizophrenia

Congxin Chen
Jingjing Yao
Yiding Lv
Xiaoxin Zhao
Xinyue Zhang
Jiaxi Lei
Yuan Li
Yuxiu Sui

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.922272

1,967 views
6 citations

Original Research

Published on 26 Jul 2022

Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder

in Schizophrenia

Yanyan Wei
Tingting Wang
Guoguang Li
Junhui Feng
Lianbang Deng
Haiting Xu
Lu Yin
Jinbao Ma
Dongning Chen
Jingxu Chen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.941728

5,814 views
36 citations

Original Research

Published on 25 Jul 2022

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia

in Schizophrenia

Aleksandra Koricanac
Aleksandra Tomic Lucic
Mirjana Veselinovic
Danijela Bazic Sretenovic
Gorica Bucic
Anja Azanjac
Olivera Radmanovic
Mirjana Matovic
Marijana Stanojevic
Aleksandra Jurisic Skevin

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.925757

3,831 views
1 citation

Original Research

Published on 25 Jul 2022

Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia

in Schizophrenia

Xu Yuan Yin
Yuan Cai
Zhen Hua Zhu
Chang Ping Zhai
Jian Li
Cai Fang Ji
Peng Chen
Jing Wang
Yi Ming Wu
Raymond C. K. Chan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.957671

2,287 views
4 citations

Brief Research Report

Published on 22 Jul 2022

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR

in Schizophrenia

Anne Emilie Stürup
Carsten Hjorthøj
Nikolai Albert
Signe Dolmer
Merete Birk
Bjørn H. Ebdrup
Lene Falgaard Eplov
Heidi Jensen
Ditte Lammers Vernal
Helene Speyer

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.910703

1,787 views
6 citations

Original Research

Published on 18 Jul 2022

Optimizing functional near-infrared spectroscopy (fNIRS) channels for schizophrenic identification during a verbal fluency task using metaheuristic algorithms

in Schizophrenia

Dong Xia
Wenxiang Quan
Tongning Wu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.939411

2,044 views
10 citations

Original Research

Published on 15 Jul 2022

Effects of a virtual reality serious game training program on the cognitive function of people diagnosed with schizophrenia: A randomized controlled trial

in Schizophrenia

Xu Wang
Xiaomin Kou
Xiandong Meng
Jianying Yu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.952828

3,755 views
7 citations

Navigation group

Articles

Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance

Editorial: Substance use and the psychosis spectrum

The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia

Peripheral inflammation levels associated with degree of advanced brain aging in schizophrenia

Increased brain gyrification and subsequent relapse in patients with first-episode schizophrenia

Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia

‘An experience of meaning’: A 20-year prospective analysis of delusional realities in schizophrenia and affective psychoses

High-intensity interval training may reduce depressive symptoms in individuals with schizophrenia, putatively through improved VO2max: A randomized controlled trial

Mindfulness, cognitive fusion, and self-compassion in patients with schizophrenia spectrum disorders—A cross-sectional study

Aberrant Functional Connectivity of the Orbitofrontal Cortex Is Associated With Excited Symptoms in First-Episode Drug-Naïve Patients With Schizophrenia

Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia

Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia

Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR

Optimizing functional near-infrared spectroscopy (fNIRS) channels for schizophrenic identification during a verbal fluency task using metaheuristic algorithms

Effects of a virtual reality serious game training program on the cognitive function of people diagnosed with schizophrenia: A randomized controlled trial